
Antonio Abbate
C. Heede Professor of Cardiology, Medicine- Cardiovascular Medicine · University of Virginia Medical Center
Credentials: · · · ·
History

- 2023–2026
Cardiovascular Disease

Research
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Review · Nature reviews. Immunology · 2021 · Last of 11 authors · 776 citations
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Review · Circulation Research · 2020 · First of 6 authors · 614 citations
The NLRP3 inflammasome in acute myocardial infarction
Review · Nature Reviews Cardiology · 2018 · 565 citations
- BT
179 papers
- CT
70 papers · 38 as a resident

52 papers · 52 as a fellow
- RM
51 papers · 5 as a resident
- GV
42 papers
- DK
41 papers · 29 as a fellow

38 papers

37 papers · 36 as a resident
Grants
- 2024–2028
Modeling of Cell-Specific LRP1 Signaling in Acute Myocardial Infarction
National Heart, Lung, and Blood Institute · R01
PI · $2.3M · University of Virginia
- 2026–2027
Targeted Interleukin-1 Blockade in Acute Systolic Heart Failure
National Heart, Lung, and Blood Institute · R61
PI · $752.4K · Virginia Commonwealth University
- 2022–2027
Prevention of Heart Failure with IL-1 Blockade: A Mechanistic Study
National Institute on Aging · R01
PI · $3.1M · Virginia Commonwealth University
- 2020–2026
Unconventional IL-1 Signaling in Heart Failure
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.9M · University of Virginia
Clinical trials
- 2025–2026
Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI
Principal investigator · Active not recruiting · Phase 1, Phase 2
Implicit Bioscience
- 2024–2026
IC14 for Treatment of Acute Decompensated Heart Failure
Principal investigator · Active not recruiting · Phase 1, Phase 2
Implicit Bioscience
- 2024–2028
Colchicine in Acutely Decompensated HFREF
Principal investigator · Recruiting · Phase 4
University of Virginia
- 2020
Principal investigator · Completed · Phase 2
Virginia Commonwealth University